Phenylpiracetam hydrazide: Difference between revisions
Appearance
Content deleted Content added
No edit summary |
Argenteus.CG (talk | contribs) The chemical at hand is not a designer drug |
||
Line 44: | Line 44: | ||
}} |
}} |
||
'''Phenylpiracetam hydrazide''', also known as '''fonturacetam hydrazide''',<ref>{{cite journal|title=International Nonproprietary Names for Pharmaceutical Substances (INN). Recommended International Nonproprietary Names: List 63|journal=WHO Drug Information|date=2010|volume=24|issue=1|page=56|url=http://apps.who.int/medicinedocs/documents/s17753en/s17753en.pdf|accessdate=26 November 2015}}</ref> is a [[ |
'''Phenylpiracetam hydrazide''', also known as '''fonturacetam hydrazide''',<ref>{{cite journal|title=International Nonproprietary Names for Pharmaceutical Substances (INN). Recommended International Nonproprietary Names: List 63|journal=WHO Drug Information|date=2010|volume=24|issue=1|page=56|url=http://apps.who.int/medicinedocs/documents/s17753en/s17753en.pdf|accessdate=26 November 2015}}</ref> is a putative [[nootropic]] that is a [[derivative (chemistry)|derivative]] of [[phenylpiracetam]] in which the [[carboxamide|amide]] group is replaced with a [[hydrazide]] group. It was first reported by a Russian research group in 1980 as part of a series of chemical compounds investigated as [[anticonvulsant]]s.<ref name=Glozman>{{cite journal | title = Synthesis and anticonvulsive activity of 4-phenyl-2-pyrrolidinone-1-acetic acid amides |author1=Glozman, O. M. |author2=Morozov, I. S. |author3=Zhmurenko, L. A. |author4=Zagorevskii, V. A. | journal = Khimiko-Farmatsevticheskii Zhurnal | date = 1980 | volume = 14 | issue = 11 | pages = 43–48 | language = Russian}}</ref> In an electroshock test it was found to have an [[Effective dose (pharmacology)|ED<sub>50</sub>]] of 310 mg/kg.<ref name=Glozman/> |
||
==See also== |
==See also== |
Revision as of 21:18, 23 February 2018
Clinical data | |
---|---|
Trade names | Phenylpiracetam hydrazide |
Other names | Fonturacetam hydrazide |
Pregnancy category |
|
Routes of administration | Oral |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C12H15N3O2 |
Molar mass | 233.27 g/mol g·mol−1 |
3D model (JSmol) | |
Chirality | Racemic mixture |
| |
| |
(what is this?) (verify) |
Phenylpiracetam hydrazide, also known as fonturacetam hydrazide,[1] is a putative nootropic that is a derivative of phenylpiracetam in which the amide group is replaced with a hydrazide group. It was first reported by a Russian research group in 1980 as part of a series of chemical compounds investigated as anticonvulsants.[2] In an electroshock test it was found to have an ED50 of 310 mg/kg.[2]
See also
References
- ^ "International Nonproprietary Names for Pharmaceutical Substances (INN). Recommended International Nonproprietary Names: List 63" (PDF). WHO Drug Information. 24 (1): 56. 2010. Retrieved 26 November 2015.
- ^ a b Glozman, O. M.; Morozov, I. S.; Zhmurenko, L. A.; Zagorevskii, V. A. (1980). "Synthesis and anticonvulsive activity of 4-phenyl-2-pyrrolidinone-1-acetic acid amides". Khimiko-Farmatsevticheskii Zhurnal (in Russian). 14 (11): 43–48.